Publications from the National Academies of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes Health and Medicine Division (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Considerations for the Design of a Systemic Review of ...
Released: December 29, 2015
The National Institutes of Health- and many other organizations and individuals worldwide- are interested in the state of the science of preventing Alzheimer's disease, mild cognitive impairment, and age-related cognitive decline.
Assessing the Impact of Applications of Digital Health Records ...
Released: December 08, 2015
On July 20, 2015, the IOM’s Forum on Neuroscience and Nervous System Disorders held a public session at the 2015 Alzheimer’s Association International Conference in Washington, DC, to assess the impact of DHRs on Alzheimer’s disease research. “AD is the most common cause of dementia in older adults.” An estimated 46.8 million people worldwide are currently living with dementia, and the prevalence is expected to double every year for the next 20 years. Given the few therapies currently available to treat the symptoms of AD, compared to other central nervous system disorders, this session explored how DHRs may be used to help improve clinical trial design and methodology for AD research.
Rapid Medical Countermeasure Response to Infectious ...
Released: October 12, 2015
On March 26 and 27, 2015, the Institute of Medicine (IOM) Forum on Medical and Public Health Preparedness for Catastrophic Events; Forum on Drug Discovery, Development, and Translation; and Forum on Microbial Threats co-convened a workshop in Washington, DC, to discuss how to achieve rapid and nimble MCM capability for new and emerging threats.
Providing Sustainable Mental and Neurological Health Care ...
Released: October 01, 2015
Mental, neurological, and substance use (MNS) disorders are the leading cause of disability and the 10th leading cause of death worldwide. Despite this high burden, there is a significant shortage of resources available to prevent, diagnose, and treat these disorders. Approximately four out of five people with serious MNS disorders living in low- and middle-income countries do not receive needed health services, with Sub-Saharan Africa having one of the largest treatment gaps.
Non-Invasive Neuromodulation of the Central Nervous System ...
Released: July 27, 2015
Given the growing interest in non-invasive neuromodulation technologies, the Institute of Medicine’s Forum on Neuroscience and Nervous System Disorders convened a workshop, inviting a range of stakeholders—including developers of devices and new technologies, researchers, clinicians, ethicists, regulators, and payers—to explore the opportunities, challenges, and ethical questions surrounding the development, regulation, and reimbursement of these devices for the treatment of nervous system disorders as well as for non-therapeutic uses, including cognitive and functional enhancement.
Enabling Discovery, Development, and Translation of ...
Released: July 22, 2015
On February 24, 2015, the Institute of Medicine’s (IOM’s) Forum on Neuroscience and Nervous Disorders convened key stakeholders at a workshop in Washington, DC, to explore how best to enable the discovery, development, and translation of treatments for cognitive dysfunction in depression, including a focus on the regulatory path forward.
Psychosocial Interventions for Mental and Substance Use ...
Released: July 14, 2015
The Institute of Medicine (IOM) convened an expert committee to identify key steps to ensure that evidence-based, high-quality care is provided to individuals receiving mental health and substance use services. The resulting report, Psychosocial Interventions for Mental and Substance Use Disorders, details the reasons for the gap between what is known to be effective and what is currently practiced, and it offers recommendations for how best to address this gap by proposing a framework that can be used to establish standards for psychosocial interventions.
International Infectious Disease Emergencies and Domestic ...
Released: July 07, 2015
The Institute of Medicine’s (IOM’s) Forum on Medical and Public Health Preparedness for Catastrophic Events organized a session at the 2015 Preparedness Summit to discuss international public health emergencies, such as Ebola, and their corresponding impact on state and local public health and health care systems.
Financial Incentives to Encourage Development of Therapies ...
Released: July 06, 2015
The Institute of Medicine (IOM) Forum on Neuroscience and Nervous System Disorders, in collaboration with the IOM Forum on Drug Discovery, Development, and Translation, convened a workshop on January 20–21, 2015, to explore policy changes that might increase private sector investment in research and development (R&D) innovation that fills unmet medical needs for CNS disorders.
Strategies to Improve Cardiac Arrest Survival: A Time to Act ...
Released: June 30, 2015
The Institute of Medicine conducted a study on the current status of, and future opportunities to improve, cardiac arrest treatment and outcomes in the United States. This report examines the complete system of response to cardiac arrest in the United States and identifies opportunities within existing and new treatments, strategies, and research that promise to improve survival and recovery of patients.